Company 2cureX AB (publ) Nasdaq Stockholm
Equities
SE0010468124
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Grith Hagel
FOU | Founder | 65 | 05-12-31 |
Ole Thastrup
FOU | Founder | 71 | 05-12-31 |
Director of Finance/CFO | 48 | 21-01-31 | |
Raphael Gruber
CTO | Chief Tech/Sci/R&D Officer | 60 | 22-06-30 |
Jacob Thastrup
PRN | Corporate Officer/Principal | - | - |
Tabea Sturmheti
PRN | Corporate Officer/Principal | 39 | 16-12-31 |
Corporate Officer/Principal | 59 | 21-07-31 | |
Manuel Fernández
LAW | General Counsel | - | 22-04-20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ole Thastrup
FOU | Founder | 71 | 05-12-31 |
Chairman | - | Nov. 13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,602,916 | 6,427,381 ( 36.51 %) | 0 | 36.51 % |
Company contact information
![address 2cureX AB (publ)](https://cdn.zonebourse.com/static/address/61175215.png)
Sector
1st Jan change | Capi. | |
---|---|---|
-37.33% | 8.55B | |
+14.86% | 3.8B | |
+7.38% | 2.44B | |
-25.96% | 1.87B | |
-17.30% | 1.74B | |
+36.49% | 1.19B | |
+32.58% | 830M | |
-7.64% | 711M | |
-18.37% | 589M |